A biotech startup called Loyal is developing a pill designed to help large dogs live longer.
Early trials suggest the medicine targets aging itself, aiming to extend healthy years rather than just add time at the end.
Regulators are currently reviewing the data, with a potential launch around 2026.
If approved, it could turn longevity medicine for pets into something owners can discuss with their vet.
Early trials suggest the medicine targets aging itself, aiming to extend healthy years rather than just add time at the end.
Regulators are currently reviewing the data, with a potential launch around 2026.
If approved, it could turn longevity medicine for pets into something owners can discuss with their vet.
A biotech startup called Loyal is developing a pill designed to help large dogs live longer.
Early trials suggest the medicine targets aging itself, aiming to extend healthy years rather than just add time at the end.
Regulators are currently reviewing the data, with a potential launch around 2026.
If approved, it could turn longevity medicine for pets into something owners can discuss with their vet.
Language
VN
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Arabic